Question 1

Who is R. Mark Adams?

Accepted Answer

R. Mark Adams serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 25 insider transactions totaling $1.7M over their tenure at the company.

Question 2

What is R. Mark Adams's role at Adaptive Biotechnologies Corp?

Accepted Answer

R. Mark Adams holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.

Question 3

Is R. Mark Adams buying or selling ADPT stock?

Accepted Answer

R. Mark Adams has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are R. Mark Adams's largest insider transactions?

Accepted Answer

The largest transaction by R. Mark Adams was on Jun 17, 2021, when they sold $583.3K worth of ADPT shares. This transaction involved 14,583 shares at $40.00 per share.

Question 5

What is R. Mark Adams's trading accuracy?

Accepted Answer

R. Mark Adams has a Personal Accuracy Score of 84/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is R. Mark Adams associated with?

Accepted Answer

R. Mark Adams has filed Form 4 transactions for 1 different company. Their primary association is with Adaptive Biotechnologies Corp (ADPT), where they serve as Executive.

Question 7

How much ADPT stock does R. Mark Adams own?

Accepted Answer

R. Mark Adams currently owns 175,361 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is R. Mark Adams's equity in Adaptive Biotechnologies Corp?

Accepted Answer

R. Mark Adams's equity position in Adaptive Biotechnologies Corp consists of 175,361 shares valued at approximately $0. As Executive, they have executed 25 insider transactions, with $0 in purchases and $1.7M in sales.

Question 9

Where can I find R. Mark Adams's SEC Form 4 filings?

Accepted Answer

All of R. Mark Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Mark Adams has 25 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.

Question 10

What is R. Mark Adams's net worth from ADPT?

Accepted Answer

Based on their current ADPT stock holdings, R. Mark Adams has equity worth approximately $0 in Adaptive Biotechnologies Corp. This value is based on 175,361 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Apr 11, 2023	ADPT	$19.9K	Sale	2,308	$8.63	Planned
Apr 10, 2023	ADPT	$6.9K	Sale	817

R. Mark Adams

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

R. Mark Adams Trading Summary

How Much ADPT Stock Does R. Mark Adams Own?

Is R. Mark Adams Buying or Selling ADPT?

R. Mark Adams's Recent Stock Transactions

Frequently Asked Questions

Track R. Mark Adams's Trades